ea0098c30 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023
Lareef Ishara
, Vijayvergia Namrata
, Handorf Elizabeth
, Kunz Pamela L.
, Alkim Emil
, Burke Lauren M.
, Catalano Paul
, Graham Noah
, Levin Laura
, Li Weier
, Meeker Caitlin
, Rubin Daniel
, Sridharan Anush
, O'Dwyer Peter J.
, Wong Terence Z.
, Anaokar Jordan
Background: Evaluating treatment (Tx) Response in NETs using CT/MRI scans can be difficult. Previous studies, including the E2211, have shown improved progression-free survival (PFS) but no significant difference in Rp as measured by RECIST 1.1 (R1.1) criteria. Therefore, it is difficult to determine Tx effectiveness with short-term imaging, further complicated by differences in imaging protocols and inter-reader variability. Incorporating tumor density, using smaller threshol...